FindTrial
Sign In

EFFICACY OF BUPIVACAINE WITH DEXMEDETOMODINE FOR BRACHIAL PLEXUS BLOCK

COMPARISION OF EFFECT OF 0.25% BUPIVACAINE WITH DEXMEDETOMODINE AND 0.25% BUPIVACAINE ALONE IN BRACHIAL PLEXUS BLOCK BY SUPRACLAVICULAR APPROACH

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/12/004250
Enrollment
60
Registered
2013-12-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients posted for upper limb orthopaedic surgeries

Interventions

Intervention1: dexmedetomidine with bupivacaine: single dose of dexmedetomidine 0.5ml (50mcg)with o.25% 34ml bupivacaine is injected into brachial plexus through supraclvicular approach before the sur

Sponsors

Father Muller Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA(American Society of Anaesthesiologists) grade 1 and 11 2. between the ages of 18-60years, of either sex 3. Undergoing orthopaedic surgeries on upper limb

Exclusion criteria

Exclusion criteria: 1. Patients on adrenoreceptor agonist and antagonist therapy 2. Known hypersensitivity to local anaesthetics 3. Uncontrolled diabetes milletus 4. Pregnant woman 5. Preexisting peripheral neuropathy 6.Patients with bleeding disorder 7. ASA 111 and above

Design outcomes

Primary

MeasureTime frame
To compare the effects of 0.25% bupivaciane with dexmedetomidine and 0.25% bupivaciane alone in brachial plexus blockTimepoint: 11/10/2012 to 11/10/2014—

Secondary

MeasureTime frame
1.To study the effects of 0.25% bupivacaine with dexmedetomodine in brachial plexus block 2.To study the effects of 0.25% bupivacaine in brachial plexus block Timepoint: 11/10/2012 to 11/10/2014—

Countries

India

Contacts

Public ContactDr Radhesh Hegde

Father Muller Medical College

radheshhegde68@gmail.com9845085007

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026